RBC Capital raises price targets on biotech stocks

Statements (8)

1. ▲ Bullish

   RBC Capital analyst Leonid Timashev increased price target on ONC to $436.

   finance.yahoo.comJun 30, 2026 13:07 UTC
2. ▲ Bullish

   RBC Capital raised its price target for Edgewise Therapeutics, Inc. to $59

   finance.yahoo.comJun 25, 2026 12:41 UTC
3. ▲ Bullish

   RBC raises price target for PicS N.V. to $280

   finance.yahoo.comJun 20, 2026 20:34 UTCHigh importance
4. ▲ Bullish

   RBC Capital set a $182 price target for Revolution Medicines Inc. (RVMD)

   finance.yahoo.comJun 13, 2026 19:30 UTC
5. ▲ Bullish

   RBC Capital raised its price target on Neurocrine Biosciences from $180 to $183

   finance.yahoo.comJun 4, 2026 16:49 UTC
6. ▲ Bullish

   RBC raised its price target on Marvell Technology stock to $240

   barchart.comMay 28, 2026 19:14 UTC
7. ● Neutral

   CG Oncology reported quarterly sales of $1.083 million, beating analyst consensus estimate

   benzinga.comMay 11, 2026 16:40 UTC
8. ▲ Bullish

   RBC Capital raised its price target on CG Oncology from $73 to $79

   finance.yahoo.comMay 10, 2026 23:14 UTC